Granulocyte colony-stimulating factor expression as a prognostic biomarker in non-small cell lung cancer

Oncology Reports

Volumn 25, Issue 6, 2011, Pages 1541-1544

  Stathopoulos, G P ^a   Armakolas, A ^b   Tranga, T ^c   Marinou, H ^a   Stathopoulos, J ^a   Chandrinou, H ^a  

^a Errikos Dunant Hospital   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c Bioanalytica Genotype SA   (Greece)

Author keywords

Granulocyte colony stimulating factor; Prognostic factor

Indexed keywords

CISPLATIN; DEXAMETHASONE; GEMCITABINE; GRANULOCYTE COLONY STIMULATING FACTOR; PACLITAXEL; TUMOR MARKER;

ADULT; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOCYTE COUNT; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MULTIPLE CYCLE TREATMENT; PATIENT CODING; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SURVIVAL RATE; UNSPECIFIED SIDE EFFECT;

CARCINOMA, NON-SMALL-CELL LUNG; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 79954465657     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1226     Document Type: Article

References (15)

1. Jardin F, Vasse M, Debled M, Dominique S, Courville F, Callonnec F, Buchonnet G, Thiberville L and Tilly H: Intense paraneoplastic neutrophilic leukemoid reaction related to a G-CSF secreting lung sarcoma. Am J Hematol 80: 243-245, 2005. (Pubitemid 41579549)
2. Robinson WA: Granulocytosis in neoplasia. Ann NY Acad Sci 230: 212-215, 1974.
3. Nakada T, Sato H, Inoue F, Mizorogi F, Nagayama K and Tanaka T: The production of colony-stimulating factors by thyroid carcinoma is associated with marked neutrophilia and eosinophilia, case report. Intern Med 35: 815-820, 1996. (Pubitemid 126476959)
4. Baldwin GC, Gasson JC, Kaufman SE, Quan SG, William RE, Avalos BR, Gazdar AF, Golde GC and Dipersio JF: Non-hematopoietic tumor cells express functional GM-CSF receptors. Blood 73: 1033-1037, 1989. (Pubitemid 19078384)
5. Thacker JD, Dedhar S and Hogge DE: The effect of GM-CSF and G-CSF on the growth of human osteosarcoma cells in vitro and in vivo. Int J Cancer 56: 236-243, 1994. (Pubitemid 24076125)
6. Berdel WE, Danhauser-Riedl S, Steinhauser G and Winton EF: Various human hematopoietic growth factors (interleukin-3, GM-CSF, G-CSF) stimulate clonal growth of non-hematopoietic tumor cells. Blood 73: 80-83, 1989. (Pubitemid 19040957)
7. Watanabe M, Ono K, Ozeki Y, Tanaka S, Aida S and Okuno Y: Production of granulocyte -macrophage colony- stimulating factor in a patient with metastatic chest wall large cell carcinoma. Jpn J Clin Oncol 28: 559-562, 1998. (Pubitemid 128523178)
8. Gasson JC, Weisbart RH, Kaufman SE, Clark SC, Hewick RM, Wong GG and Golde DW: Purified human granulocyte-macrophage colony-stimulating factor: direct action on neutrophils. Science 224: 1339-1341, 1984.
9. Antman KS, Griffin JD, Elias A, Socinski MA, Ryan L, Cannistra SA, Dette D, Whitley M, Emilfrei RN and Schnipper LE: Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression. N Engl J Med 319: 593-598, 1988.
10. Saito S, Fukunag R, Ichijo M and Nagata S: Expression of granulocyte colony-stimulating factor and its receptor at the fetomaternal interface in murine and human pregnancy. Growth Factors 10: 135-143, 1994. (Pubitemid 24170025)
11. Nagata S: Granulocyte colony-stimulating factor. In: Handbook of Experimental Pharmacology Peptide Growth Factors and Their Receptors. Sporn MB and Roberts AB (eds). Springer-Verlag, Berlin, p699, 1990.
12. Gabrilove JL: Clinical applications of granulocyte colony-stimulating factor (G-CSF). Growth Factors 6: 187-191, 1992.
13. Nagata S: Cytokine colony-stimulating factor. In: The Cytokine Handbook. Thomson AW (ed). Academic London, pp371-385, 1994.
14. Felser JM: Clinical use of hematopoietic growth factors for control of infections after high-dose chemotherapy. Ann NY Acad Sci 730: 235-242, 1994.
15. Harmenberg J, Hoglund M and Hellstrom-Lindberg E: G- and GM-CSF in oncology and oncological haematology. Eur J Haematol (Suppl.) 55: 1-28, 1994.